Is UL a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Power Brands and premiumization, with revenue scale at Tens of billions of euros in annual turnover (reported in euros; UL is a dollar-denominated ADR), spread across roughly 190 countries; verify live figures before acting. The bear case rests on the main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. Analysts covering it are spread from $67.05 to $70.05, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $67.05, +0.9% from the $66.46 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Power Brands and premiumization. Unilever has concentrated its portfolio on a smaller group of Power Brands (Dove, Knorr, Hellmann's, Vaseline, Rexona, and others) that make up the large majority of turnover and have been growing faster than the total business. The most optimistic analyst target on UL is $70.05, +5.4% from the $66.46 price. That figure is only reachable if this thesis works close to its best case.

The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. Input-cost inflation in commodities and packaging can squeeze margins, and heavy price increases risk losing volume to private label and cheaper rivals. As an ADR, UL results are reported in euros, so a stronger dollar reduces the dollar value of sales, earnings, and the dividend for US holders. Execution risk is real: management overhauls, thousands of role changes, and integrating the shift to a category-led model can distract the organization. The retained minority stake in The Magnum Ice Cream Company is an overhang the company plans to sell down, and some brands (such as Ben & Jerry's, now part of the demerged entity) have a history of activism-related controversy. Slower developed-market volumes and intense competition round out the picture. The most pessimistic published target is $67.05, +0.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Unilever PLC is one of the world's largest consumer-goods companies, and UL is its NYSE-listed ADR (the London line trades as ULVR, with a further listing in Amsterdam).

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Power Brands and premiumization) stalling in the reported numbers rather than in the narrative, the risk above (the main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The case for it is a defensive, dividend-paying global staples business that is simplifying its portfolio (after spinning off ice cream), focusing on Power Brands and beauty, and cutting costs to lift margins. The case against it is that staples grow slowly, the turnaround is still unproven, and as a euro-reporting ADR its dollar results move with currency. Weigh both against your portfolio.

UL is an American Depositary Receipt (ADR) that trades on the NYSE in US dollars and represents shares of Unilever PLC, whose primary listing (ULVR) is in London, with a further listing in Amsterdam. The ADR lets US investors buy and hold the company through a normal US brokerage account. The underlying business is identical; the ADR just adds a dollar wrapper, possible small ADR fees, and dividends converted from euros to dollars.

Unilever completed the demerger of its ice cream business in December 2025, creating a separate listed company, The Magnum Ice Cream Company, which owns Magnum, Ben & Jerry's, Cornetto, and other ice cream brands. Existing Unilever holders received shares in the new company (roughly one for every five Unilever shares). Unilever kept a minority stake it plans to sell down over time. After the split, Unilever no longer includes ice cream in its results.